SNSS - Sunesis Pharmaceuticals EPS beats by $0.02 misses on revenue May, 07 2020 04:08 PM Viracta Therapeutics Inc Com Sunesis Pharmaceuticals (NASDAQ:SNSS): Q1 GAAP EPS of -$0.05 beats by $0.02.More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...